#Antibody-Drug Conjugates (ADCs) are a class of targeted cancer therapies that combine the specific targeting capability of monoclonal antibodies with the cell-killing properties of cytotoxic drugs. https://wemarketresearch.com/reports/antibody-drug-conjugates-market/132 #AntibodyDrugConjugates #ADCs #CancerTherapy #TargetedTherapies #OncologyResearch #Biopharmaceuticals #DrugDevelopment #PrecisionMedicine #CancerTreatment #PharmaInnovation

The global genomics market is growing rapidly, reaching USD 34.2B by 2025 and USD 66.4B by 2035, with a 14.6% annual growth rate, driven by tech advances and research. Read more: https://wemarketresearch.com/reports/genomics-market/1056 #Genomics #Biotech #PrecisionMedicine #GeneticResearch #DNASequencing #HealthcareInnovation #Biotechnology #GenomicMedicine #PersonalizedMedicine #DrugDiscovery #MedicalResearch #GeneticTesting #LifeSciences #Biopharma #FutureOfMedicine

#Antibody_Drug_Conjugates (ADCs) are a class of targeted cancer therapies that combine an antibody with a cytotoxic (cell-killing) drug. Read More: https://wemarketresearch.com/reports/antibody-drug-conjugates-market/132 #AntibodyDrugConjugates #ADCs #CancerTreatment #TargetedTherapy #Immunotherapy #CancerResearch #Oncology #PrecisionMedicine #Pharmaceuticals #Biopharma #CancerTherapy

Space-Based Biopharmaceuticals Market Research Report 2034 Dataintelo, a leading provider of market research and business intelligence, is proud to announce the release of its latest report, "Global Space-Based Biopharmaceuticals Market – Trends, Growth Drivers, Challenges, and Forecast (2024-2032)." The report provides an in-depth analysis of a transformative industry at the intersection of biotechnology and space science, offering critical insights into the dynamic opportunities and challenges shaping this burgeoning market. Claim Your Free Market Report Sample Now @ https://dataintelo.com/request-sample/601091 The Space-Based Biopharmaceuticals Revolution The field of space-based biopharmaceuticals involves leveraging microgravity environments aboard spacecraft and space stations to advance drug discovery, development, and production. Researchers have found that the microgravity conditions in space can significantly enhance the structure and stability of proteins, crystals, and other biological components critical to drug development. As space commercialization accelerates, partnerships between space exploration companies and biopharmaceutical firms are fueling unprecedented innovation. From more efficient protein crystallization to novel cancer treatments, space-based research is poised to disrupt traditional pharmaceutical processes on Earth. Get Free Exclusive Sample Report @ https://dataintelo.com/request-sample/601091 Key Highlights of the Report Market Size and Growth Projections The global space-based biopharmaceuticals market is projected to experience robust growth, with a compound annual growth rate (CAGR) exceeding 18.5% from 2024 to 2032, driven by advances in space exploration technology and the rising demand for innovative therapies. Emerging Applications Key applications of space-based research include: Drug development through protein crystallization. Manufacturing of biologics and cell-based therapies. Exploring new treatments for chronic and degenerative diseases. Conducting cutting-edge cancer research. Buy the complete report @ https://dataintelo.com/report/space-based-biopharmaceuticals-market

Health and Wellness Food Market Share, Trend, Segmentation and Forecast to 2030  Health and Wellness Food Market Globally at a rate of 9.3%in the forecast period 2023 to 2030. Profound Questions Answered in this Report: What is the growth rate of various stages in the value chain of the industry? Which region has the highest growth rate and size of the emerging market by value in 2022? Who are the competitive players in Global Urothelial Cancer Drugs Market? Which region has the largest share and degree of competition in the industry? What is the CAGR of the market during the forecast period 2022 to 2028? Which region is expected to hold the highest market share for the market?   What is the main driver of the Global Urothelial Cancer Drugs Market?   What is sales volume, revenue, and price analysis of top players of the market?   What are the market opportunities and threats faced by the vendors in the industry?   What has been the impact of COVID-19 on the Global Urothelial Cancer Drugs Market?     Get the sample copy of the Report here https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-health-and-wellness-food-market Health and Wellness Food Mark Scope and Market Size The global health and wellness food market is segmented based on type, calorie content, nature, fat content, category, free from the category, and distribution channel. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications. Type Functional Food Fortified and Healthy Bakery Products Healthy Snacks BFY Foods Beverages Chocolates Others By type, the global health and wellness food market is segmented into functional food, fortified and healthy bakery products, healthy snacks, BFY foods, beverages, chocolates, and others.   Calorie Content   No calorie Low calories Health and Wellness Food Market Scenario According to Data Bridge Market Research, the market for health and wellness food is expected to gain growth because of the rise in the awareness regarding the health benefits of healthy foods across the globe. In addition to this, rise in the importance of organic food, increasing food sensitivities, rising fitness institutions and enthusiasts, which in turn increases the demand for the product demand and increase in the disposable income and rapid urbanization are also acting as a key determinant favoring the growth of the health and wellness food market. On the flip side, high cost of health and wellness food will likely obstruct the growth of the market.   Now the question is which are the other regions that health and wellness food market is targeting? Data Bridge Market Research has estimated Asia-Pacific to show profitable growth owing to the increasing food sensitivities, rise in the importance of organic food, rising fitness institutions and rise in the importance of organic food within this particular region. Global Health and Wellness Food Market Regional Analysis/Insights The competitive global health and wellness food market provide details about the competitors. Details include company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points are only related to the company’s focus on the global health and wellness food market. Key Market Drivers & Challenges   One of the main drivers of the growth of the health and wellness food market is the rising number of people who are changing their eating habits, adopting a healthy nutritional diet, and leading active lifestyles. Global awareness of the value of a healthy diet, regular exercise, and physical activity is growing, which is crucial for the development of the industry under consideration.   Nutritional diets have been associated with mental, physical, and emotional well-being, and the absence of such balanced diets can result in illnesses and bad health. The demand for nutrient-rich food is rising as a result. Although factors such as the high cost of health and wellness food may impede the market growth. Who are the major players operating in the market? The major players operating in the Health and Wellness Food Market are DSM (Netherlands), BASF SE (Germany), Lonza Group (Switzerland), Glanbia Plc (Ireland), ADM (US), Farbest Brands (US), Stern Vitamin GmbH & Co. KG (Germany), Addison (France), BTSA Biotechnologies Aplicadas S.L. (Spain)Rabar Pty Ltd (Australia) Golden Omega (Chile), Kino mega Biopharma Inc. (China), Sinomega Biotech Engineering Co. Ltd. (China), Polaris (US), Pharma Marine AS (Norway), Huatai Biopharma (China), ALGISYS LLC (US), and Bio search Life (Spain). What is the growth rate of the Market? The Health and Wellness Food Market will grow at a CAGR of 9.3% during the forecast by 2029. Market Analysis and Insights of the Health and Wellness Food Market The global health and wellness food market is growing faster than the packaged food industry, owing to shifting customer tastes toward a more natural and functional offering to adopt a more holistic approach to a balanced diet. The growing number of individuals altering their eating habits and embracing a balanced nutritional diet and active lifestyle is a major element driving the growth of the health and wellness food industry People worldwide are realizing the value of a healthy diet, exercise, and regular physical activity, which is critical for the market's growth. However, high prices of health and wellness foods and high maintenance costs may Research Methodology: Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts. Get Full Access to the Report https://www.databridgemarketresearch.com/reports/global-health-and-wellness-food-market MAJOR TOC OF THE REPORT Chapter One: Introduction Chapter Two: Market Segmentation Chapter Three: Market Overview Chapter Four: Executive Summary Chapter Five: Premium Insights Chapter Six: Health and Wellness Food Market   Get TOC Details https://www.databridgemarketresearch.com/toc/?dbmr=global-health-and-wellness-food-market   Browse Related Reports@ https://www.databridgemarketresearch.com/reports/global-health-and-wellness-food-market https://www.databridgemarketresearch.com/reports/middle-east-and-africa-dermal-fillers-market https://www.databridgemarketresearch.com/reports/global-animal-feed-market https://www.databridgemarketresearch.com/reports/global-pistachio-market https://www.databridgemarketresearch.com/reports/global-active-pharmaceutical-ingredient-api-market    About Us: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market   Contact: Data Bridge Market Research Tel: +1-888-387-2818 Email: Sopan.gedam@databridgemarketresearch.com      

Fill Finish Biopharmaceuticals market Share, Growth Analysis by 2035 Given the growing pipeline of biologics, lack of technical expertise, and huge capital investment in the installation of fill / finish equipment, a number of drug manufacturers are turning to contract service providers in order to ensure the development of quality drug products. This evident surge in the demand for biologics fill and finish services has presented lucrative opportunities for service providers having necessary fill / finish capabilities. The financial opportunity within the biologics fill finish services market has been analysed across the following segments:  Type of Packaging Container  Ampoules  Cartridges  Syringes  Vials  Type of Biologic  Antibodies  Cell Therapies  Gene Therapies  Oligonucleotides  Proteins / Peptides  Vaccines  Others  Therapeutic Area  Oncological Disorders  Autoimmune Disorders  Infectious Diseases  Cardiovascular Disorders  Other Disorders  Scale of Operation  Preclinical / Clinical  Commercial  Company Size  Large  Mid-sized  Small  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America The “Biologics Fill / Finish Services Market (3rd Edition), 2022 – 2035” report features the following companies, which we identified to be key players in this domain:  AbbVie Contract Manufacturing  Asymchem  BioReliance  Boehringer Ingelheim BioXcellence  Catalent Biologics  Charles River Laboratories  Fareva  Fresenius Kabi  Glaxo SmithKline  Hetero Drugs  Intas Pharmaceuticals  Lonza  Patheon  Pierre Fabre  Recipharm  Samsun Biologics  Syngene  Takara Bio  Wacker Biotech  WuXi AppTec  WuXi Biologics Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Biologics Fill / Finish Service Providers: Market Landscape 5. Company Competitiveness Analysis 6. Biologics Fill / Finish Service Providers in North America 7. Biologics Fill / Finish Service Providers in Europe 8. Biologics Fill / Finish Service Providers in Asia-Pacific 9. Recent Partnerships 10. Recent Expansions 11. Capacity Analysis 12. Demand Analysis 13. Key Performance Indicators for Biologic Manufacturing and Fill / Finish 14. Regional Capability Assessment 15. Biologics Fill Finish Market Sizing and Opportunity Analysis 16. Future Growth Opportunities 17. Case Study: Robotic Systems in Fill / Finish Operations 18. Case Study: Ready-To-Use Packaging Components for Aseptic Fill / Finish 19. Concluding Remarks 20. Executive Insights 21. Appendix 1: Tabulated Data 22. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/biologics-fill-finish-services-market/256.html News article women's digital health market Learn from experts: do you know about these emerging industry trends? Bioavailability Enhancement Technologies TIL Therapies: A New Paradigm in Cancer Treatment Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #FillFinishManufacturing #FillFinishManufacturingMarket #BiologicsFillFinish #MarketResearch #MarketInsights

Filtration market Analysis and Trends by 2023-2035 The biopharmaceutical filtration market has been growing rapidly in recent years, driven by the increasing demand for biologics, as well as advances in filtration technologies. It is a critical step in the manufacturing process of biopharmaceutical products, and its applications are essential in ensuring the safety, quality, and efficacy of the final product. The financial opportunity within the biopharmaceutical market has been analyzed across the following segments:  Type of Filtration System  Depth Filtration System  Tangential Flow Filtration Systems  Membrane Filtration System  Other Filtration Systems  Type of Filter (based on use)  Disposable / Single-use Filters  Reusable / Multi-use Filters  Type of Assembly  Capsules  Cartridges  Others  Type of Drug Product  Antibodies  Vaccines  Recombinant Proteins  Cell Therapies  Gene Therapies  Oligonucleotides  Others  Company Size  Small / Mid-sized  Large  Key Geographical Regions  North America  Europe  Asia-Pacific  Rest of the World The “Global Filtration Market (Focus on Biologics Manufacturing), 2023 – 2035” report features the following companies, which we identified to be key players in this domain:  Asahi Kasei  Cobetter Filtration  Corning  Merck  Pall  Parker Hannifin  Sartorius  Thermo Fisher Scientific Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Biopharmaceutical Filtration: Market Landscape 5. Company Competitiveness Analysis 6. Suppliers Headquartered in North America: Company Profiles 7. Suppliers Headquartered in Europe and Asia-Pacific: Company Profiles 8. Recent Developments 9. Global Events Analysis 10. Biopharmaceutical Filtration: Market Forecast and Opportunity Analysis 11. Conclusion 12. Executive Insights 13. Appendix 1: Tabulated Data 14. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/global-filtration-market.html Learn from experts: do you know about these emerging industry trends? TCR Therapies: An Emerging Therapeutic Modality Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #membranefiltrationmarket #membranefiltrationsystem #pharmaceuticalfiltrationmarket #MarketResearch #MarketInsights

Lab Automation market Share, Growth Analysis by 2035 The diverse applications of lab automation systems, including advanced data management, high reproducibility and increased productivity in the biotechnology and pharmaceutical industries, have allowed the researchers to focus on more complex tasks. As a result, several stakeholders have been engaged in the manufacturing of user-friendly, controlled and automated instruments that can be customized as per the needs of the laboratory. The USD 7.5 billion (by 2035) financial opportunity within the lab automation market has been analyzed across the following segments:  Stage of Automation  Pre-Analytical  Analytical  Post-Analytical  Total Lab Automation  Type of Instrument  Automated Liquid Handling Systems  Automated Microplate Readers  Automated Sampling Systems  Analyzers  Automated Storage and Retrieval Systems (ASRS)  Other Instruments  End-User  Pharmaceutical and Biotechnology Companies  Research and Diagnostic Laboratories  Other End-Users  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America The Lab Automation Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:  Abbott  Anton Paar  BD  Beckman Coulter  ERWEKA  Leuze  Ortho Clinical Diagnostics  Pall Corporation  PerkinElmer  Roche Diagnostics  Siemens Healthineers  SYSTAG Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Company Competitiveness Analysis 6. Company Profiles 7. Partnerships and Collaborations 8. Patent Analysis 9. Market Forecast and Opportunity Analysis 10. Case Study: Lab Automation Software 11. Executive Insights 12. Appendix 1: Tabulated Data 13. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/lab-automation-market.html News article Biopharmaceutical Filtration Market Learn from experts: do you know about these emerging industry trends? CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications T-cell Immunotherapies: The Future of Modern Cancer Treatments Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #labautomation #laboratoryautomation #laboratoryautomationmarket #MarketResearch #MarketInsights

Cell Free Expression market Analysis and Trends by 2023-2035 The growing pipeline of biologics and challenges associated with their manufacturing have prompted stakeholders in the biopharmaceutical industry to adopt cell free expression systems for effective synthesis of biotherapeutics Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell Free System: Cell Free Expression Kits and Service Providers, 2023-2035.” The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different regions. Amongst other elements, the research report includes:  An executive summary of insights captured during our research.  A general overview of cell free systems, the different types of such systems and their composition. It provides a brief outline of the cell free expression process, highlighting several challenges and advantages associated with this technique  A detailed assessment of the current market landscape of cell free expression service providers.  A detailed assessment of the current market landscape of cell free expression kits, based on several relevant parameters.  A comprehensive company competitiveness analysis of cell free expression service providers.  A product competitiveness analysis of cell free expression kits based on various relevant parameters.  Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering cell free expression services.  Elaborate profiles of prominent players engaged in development of cell free expression kits (shortlisted based on a proprietary criterion).  A detailed analysis of recent partnerships inked between stakeholders engaged in this industry, from 2018.  An analysis of the funding and investments made in the cell free expression market, since 2018.  An in-depth analysis of various patents that have been filed / granted related to cell free system since 2015.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Cell Free System • Crude Cell Lysate-based Systems • Reconstituted Systems  Type of Host Organism • Microbial Cell Free Expression Systems • Mammalian Cell Free Expression Systems • Plant-based Cell Free Expression Systems • Other Cell Free Expression Systems  Type of Expression Method • Coupled Transcription and Translation Method • Translation Method  End-User • Pharmaceutical and Biotechnology Companies • Academic and Research Institutes • Other End-Users  Key Geographical Regions • North America • Europe • Asia Pacific • Rest of the World Key companies covered in the report  BioLinker  biotechrabbit  CellFree Sciences  Creative Biolabs  CUSABIO  Daicel Arbor Biosciences  LenioBio  Promega  Thermo Fisher Scientific  Touchlight For additional details, please visit https://www.rootsanalysis.com/reports/cell-free-expression-market.html News article Biopharmaceutical Filtration Market Learn from experts: do you know about these emerging industry trends? CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications Antiviral Drugs: The Unmet Requirement in the Pharmaceutical Space Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #Cellfreeproteinsynthesis #cellfreeproteinsynthesis #cellfreesystem #MarketResearch #MarketInsights

The opportunity within the HPAPI and cytotoxic drug manufacturing market is projected to grow at an annualized rate of ~12%, till 2035, claims Roots Analysis Highly potent compounds have emerged as one of the key modalities in the healthcare community owing to their numerous advantages, including stable nature, enhanced efficacy at lower doses, selective mechanism of action and significantly lower side effects Roots Analysis has announced the addition of “HPAPI and Cytotoxic Drug Manufacturing Market (4th Edition), 2022 – 2035” report to its list of offerings. Manufacturing of highly potent compounds is a laborious procedure, plagued with various difficulties, including high capital investment, extensive operational expertise, as well as access to advanced infrastructure and technologies. As a result, outsourcing has become a preferred business model in this domain, providing increased flexibility, reduced costs and timely launch of drugs. Further, to keep up with the evolving client requirements, several contract manufacturing organizations have upgraded their existing capabilities / facilities. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/299/request-sample.html Key Market Insights More than 140 companies claim to offer highly potent active pharmaceutical ingredients (HPAPI) and cytotoxic drug contract manufacturing services, globally Majority (44%) of the industry stakeholders are based in Europe, followed by those having headquarters in North America (35%). Further, more than 30% of the service providers claim to have the required capabilities to manufacture both HPAPIs and highly potent finished dosage forms. It is also worth mentioning that over 50% of the players offer contract manufacturing services for HPAPI and cytotoxic drugs across all the three scales of operation. Around 35% of partnership agreements were inked post 2020 Majority of the agreements related to HPAPI manufacturing were observed to be instances of acquisitions, representing 21% of the total partnerships. Further, most of the intercontinental, as well as intracontinental, deals have been inked by players based in Europe. Over 95 expansion initiatives have been observed since 2018 Around 50% of the initiatives were focused on expanding the existing highly potent compound manufacturing facilities, followed by instances of capacity expansions (27%) and new facility additions (24%). More than 65% of the expansions reported in this domain were local initiatives, followed by international initiatives (33%). Global installed HPAPI contract manufacturing capacity is currently estimated to be more than 2.5 million liters The maximum share (83%) of the current installed capacity is expected to be captured by very large players. Moreover, close to 40% of the global, installed manufacturing capacity is available with facilities located in the Europe region. North America and Europe are anticipated to capture more than 70% of the market share, by 2035 The market in Asia Pacific is likely to grow at a relatively faster pace (12.8%), in the long term. Currently, majority share (62%) of the overall HPAPI and cytotoxic drug contract manufacturing market is captured by HPAPIs; this trend is unlikely to change in the foreseen future as well. Further, in 2035, over 80% of the market share is likely to be captured by highly potent small molecules. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/hpapi-and-cytotoxic-drugs-manufacturing/299.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Biopharmaceutical Contract Manufacturing Market: Industry Trends and Global Forecasts, 2022-2035 2. ADC Contract Manufacturing Market (5th Edition): Industry Trends and Global Forecasts, 2022-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com